본문바로가기

Technological Differentiation

Advanced deep learning technology to provide unmatched precision


Core technology that sets us apart

Our patented methods have been trained on thousands of cases to yield instantaneous and precise analysis of data.

The technological differentiation of
our algorithms stems from world-class patents in:

  • 01

    Deep learning-based diagnostics
    technology

  • 02

    Diagnostic result visualization
    technology

  • 03

    Tissue slide indexing technology

  • 04

    Intelligent annotation technology


Our technology excellence has been proven and acknowledged

  • Edison Awards - Silver
    DeepDx Prostate, won Silver at the Edison Award 2021 in the Cellular Research & Disease Prevention category.
  • Camelyon17 Grand Challenge
    Our research team won first place in Camelyon17, a global image analysis competition for detection and classification of breast cancer metastases to lymph nodes.

Deep Bio continues its innovative research and development in medical AI

Prognoses
To improve the quality of medical services and reduce costs for patient to only receive the essential examination and treatment that’s right for them, Deep Bio is developing deep learning-based prognosis prediction models based on cancer tissue molecular shape.
Treatment
Along with increasing diagnostic precision, Deep Bio uses its AI capabilities to find the most optimized treatment candidates as well as contributes to time and cost savings during the development of new drugs.